Serimmune is an immune intelligence company focused on identifying and exploiting the universe of relationships between antibodies and antigens. Our proprietary technology provides a holistic view of the functional antibody repertoire to identify diverse immunogenic factors in disease and health. The company’s Serum Epitope Repertoire Analysis (SERA) technology platform combines a novel, random bacterial display peptide library with next generation sequencing, machine learning, and custom bioinformatics to reveal the many diverse antigens stimulating immunity. Serimmune’s human immunity map is a growing database that can be interrogated to fuel the development of multiplex diagnostics, vaccines and therapeutics.
Board of Directors
Founding Partner, Illumina Ventures
Partner, Illumina Ventures
President & Executive Director,
Founder & CSO, Serimmune